🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to evaluate the effect of the up-titra...
Status
Completed
Location
SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg)
Start Date
2019-03-20
Trial ID
NCT03882255
Treatments Being Tested
This study is for people who have multiple sclerosis, acute leukemia (in re...
Status
Suspended
Location
University of Chicago Medicine Comprehensive Cancer Center
Start Date
2024-01-26
Trial ID
NCT06171152
Treatments Being Tested
Cirrhosis is a form of advanced liver disease that can lead to serious comp...
Status
Recruiting
Location
Cleveland Clinic Main Campus
Start Date
2025-12-17
Trial ID
NCT07058155
The purpose of this study is to assess secukinumab high dose (every 2 weeks...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-06-25
Trial ID
NCT03504852
Treatments Being Tested
Rationale: For the past 3 years the investigators have routinely used an ax...
Status
Completed
Location
Inova Fairfax Hospital
Start Date
2012-10
Trial ID
NCT01566838
Treatments Being Tested
To compare the effects of Virtual reality and Frenkel's exercises on balanc...
Status
Unknown
Location
Alveena fatima
Start Date
2024-02-20
Trial ID
NCT06509698
Treatments Being Tested
The purpose of this study is to demonstrate the effectiveness of the "Takin...
Status
Completed
Location
Hamilton Health Sciences
Start Date
2012-04
Trial ID
NCT01572896
Treatments Being Tested
This is an international, multicenter, open-label study to assess the effic...
Status
Completed
Location
Study Site
Start Date
2014-03
Trial ID
NCT02093897
Treatments Being Tested
This is a Phase 1/2, open-label, monocentric, dose-escalation study of lena...
Status
Unknown
Location
Medical University of Innsbruck, Department for Internal Medicine I
Start Date
2010-03
Trial ID
NCT01166035
Treatments Being Tested
This Phase IV study is an a multi-centre, randomised open label, two way cr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-14
Trial ID
NCT02233803